Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 5 Observational 1 Expanded_access 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Adenocarcinoma 1

Interventions

zolbetuximab 1 brigatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Expanded_access × Adenocarcinoma × zolbetuximab × Clear all

NCT06048081 2025-09-10

Early Access Program for Zolbetuximab

Astellas Pharma Inc

Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡